- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
HBA Announces 2020 ACE Award Winners
Women’s leadership and mentoring initiatives garner Healthcare Businesswomen’s Association top honors for BD, GSK, Surgical Care Affiliates, and Walgreens Boots Alliance.
The Healthcare Businesswomen’s Association (HBA) will be recognizing BD (Becton, Dickinson and Company) GSK, Surgical Care Affiliates and Walgreens Boots Alliance as 2020 ACE Award winners for exemplary workplace initiatives that are working to close the gender and racial inequities in the healthcare and life sciences industry. The awards will be presented on Nov. 19.
HBA’s Advancement, Commitment and Engagement (ACE) Awards recognize companies committed to ensuring that gender diversity and leadership opportunities for women are part of their organizational DNA. An independent review panel of healthcare industry leaders selects ACE Award recipients for their excellence in advancing their female talent and removing the systemic barriers preventing timely progress to parity. Award criteria include measurable results, business performance, stewardship, execution, and sustainability.
The BD Women’s Initiative Network (WIN) earned recognition for re-thinking how mentoring programs can better drive career advancement and opportunities for all associates. GSK (GlaxoSmithKline) garnered honors for their Women’s Leadership Initiative (WLI), which embraces a culture of inclusion with women and men working side by side, and empowers women to realize their full potential without limitations.Surgical Care Affiliates (SCA) was selected as an award recipient for championing a Women’s Leadership Network that has resulted in significant growth in female leaders across the entire enterprise. Walgreens Boots Alliance has merited honors for its highly engaged Women of WBA business resource group (BRG). Initially established as a U.S. group, the BRG has evolved into a global network focused on increasing representation of women and People of Color across the company.
Throughout the year, the honorees’ programs are showcased across the HBA’s extensive community of healthcare and life science companies and are sought out by their peers for insights. A list of previous ACE awards recipients can be found here.
For more information on this year’s recipients, click here.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Novel GLP-1 Receptor Agonist Demonstrates Promising Results Treating Patients with Obesity
January 21st 2025Data from a Phase Ia single ascending dose study found that ASC30 demonstrated dose-proportional pharmacokinetics, a half-life of up to 60 hours, and superior pharmacokinetic properties compared to other oral GLP-1 receptor agonists.
